{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T02:04:53Z","timestamp":1783735493340,"version":"3.55.0"},"reference-count":15,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.3201\/eid2304.161876","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T13:47:15Z","timestamp":1491572835000},"page":"686-690","source":"Crossref","is-referenced-by-count":13,"title":["Antiviral Drug\u2013Resistant Influenza B Viruses Carrying H134N Substitution in Neuraminidase, Laos, February 2016"],"prefix":"10.3201","volume":"23","author":[{"given":"Tatiana","family":"Baranovich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phengta","family":"Vongphrachanh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pakapak","family":"Ketmayoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thongchanh","family":"Sisouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khampheng","family":"Chomlasack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viengphone","family":"Khanthamaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha Thuy","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliy P.","family":"Mishin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henju","family":"Marjuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Garten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Wentworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa V.","family":"Gubareva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2304.161876-201704070946-R1","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.antiviral.2013.08.023","article-title":"Neuraminidase inhibitors for influenza B virus infection: efficacy and resistance.","volume":"100","author":"Burnham","year":"2013","journal-title":"Antiviral Res"},{"key":"key-10.3201\/eid2304.161876-201704070946-R2","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.15585\/mmwr.mm6537a5","article-title":"Update: influenza activity\u2014United States and worldwide, May 22\u2013September 10, 2016.","volume":"65","author":"Budd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid2304.161876-201704070946-R3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.15585\/mmwr.mm6522a3","article-title":"Influenza activity\u2014United States, 2015\u201316 season and composition of the 2016\u201317 influenza vaccine.","volume":"65","author":"Davlin","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid2304.161876-201704070946-R4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.antiviral.2016.01.009","article-title":"Standardizing the influenza neuraminidase inhibition assay among United States public health laboratories conducting virological surveillance.","volume":"128","author":"Okomo-Adhiambo","year":"2016","journal-title":"Antiviral Res"},{"key":"key-10.3201\/eid2304.161876-201704070946-R5","first-page":"369","article-title":"Meetings of the WHO working group on surveillance of influenza antiviral susceptibility \u2013 Geneva, November 2011 and June 2012.","volume":"87","author":"World Health Organization","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"key-10.3201\/eid2304.161876-201704070946-R6","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1128\/JVI.67.6.2972-2980.1993","article-title":"Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase.","volume":"67","author":"Colman","year":"1993","journal-title":"J Virol"},{"key":"key-10.3201\/eid2304.161876-201704070946-R7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1086\/505868","article-title":"A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons.","volume":"43","author":"Kawai","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2304.161876-201704070946-R8","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1128\/AAC.01339-05","article-title":"Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use.","volume":"50","author":"Monto","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2304.161876-201704070946-R9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1086\/509925","article-title":"Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children.","volume":"44","author":"Sugaya","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2304.161876-201704070946-R10","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.antiviral.2009.10.022","article-title":"Detection of antiviral resistance and genetic lineage markers in influenza B virus neuraminidase using pyrosequencing.","volume":"85","author":"Sheu","year":"2010","journal-title":"Antiviral Res"},{"key":"key-10.3201\/eid2304.161876-201704070946-R11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.antiviral.2015.02.003","article-title":"Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014.","volume":"117","author":"Takashita","year":"2015","journal-title":"Antiviral Res"},{"key":"key-10.3201\/eid2304.161876-201704070946-R12","doi-asserted-by":"publisher","first-page":"30060","DOI":"10.2807\/1560-7917.ES.2015.20.45.30060","article-title":"Zanamivir-resistant influenza viruses with Q136K or Q136R neuraminidase residue mutations can arise during MDCK cell culture creating challenges for antiviral susceptibility monitoring.","volume":"20","author":"Little","year":"2015","journal-title":"Euro Surveill"},{"key":"key-10.3201\/eid2304.161876-201704070946-R13","unstructured":"Centers for Disease Control and Prevention. Human influenza virus real-time RT-PCR detection and characterization panel. 510(k) summary. 2008. http:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf8\/k080570.pdf."},{"key":"key-10.3201\/eid2304.161876-201704070946-R14","doi-asserted-by":"publisher","first-page":"10309","DOI":"10.1128\/JVI.01109-09","article-title":"Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses.","volume":"83","author":"Zhou","year":"2009","journal-title":"J Virol"},{"key":"key-10.3201\/eid2304.161876-201704070946-R15","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.str.2016.07.001","article-title":"A second RNA-binding site in the NS1 protein of influenza B virus.","volume":"24","author":"Ma","year":"2016","journal-title":"Structure"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/23\/4\/16-1876_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T23:31:28Z","timestamp":1732923088000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/23\/4\/16-1876_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2304.161876","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4]]}}}